Clinical Trial: Randomised Placebo-Controlled Trial of Methylcellulose and Psyllium Gels on Inulin-Induced Colonic Gas.

Aliment Pharmacol TherSep 11, 2026 (epub)
Clinical ResearchGastroenterology

Neele Dellschaft, Alaa Alhasani, Joshua E S J Reid et al.

✦ AI-curated · Sources linked

In 30 seconds

This three-way randomised crossover trial compared methylcellulose, psyllium and maltodextrin placebo, each given with inulin, in 22 healthy volunteers. MRI and breath hydrogen measurements assessed intestinal water, fibre and gas. Neither gel significantly changed overall colonic gas exposure across 0–360 minutes, but both were associated with less gas after reaching the colon (AUC 180–360 min, p = 0.02). Methylcellulose increased small- and large-bowel water measures more than psyllium. The findings suggest a possible mechanism for improving tolerance of fermentable carbohydrates, but the study did not test this in people with IBS.

Key findings

  • Methylcellulose and psyllium were associated with less colonic gas after reaching the colon (AUC 180-360 min, p = 0.02), without significantly altering AUC 0-360 min.
  • Both gels increased small-bowel free water; the increase was greater with methylcellulose than psyllium (p = 0.0005).
  • Both gels increased colonic chyme wateriness and hydrated fibre volume; both measures were greater with methylcellulose than psyllium (p = 0.01 and 0.02, respectively).
  • Breath hydrogen over 24 hours did not differ between groups (AUC 0-24 h, p = 1.0); psyllium reduced it during 0-6 hours (p = 0.008).

Why it matters

The trial provides physiological evidence that gel-forming fibres can alter intestinal water and reduce inulin-associated colonic gas after reaching the colon. Methylcellulose produced larger water-related effects than psyllium, which may be relevant to the hypothesis that fibre gels could help some people tolerate FODMAPs. However, these outcomes were measured in healthy volunteers, not patients experiencing IBS symptoms.

What to keep in mind

The study involved 22 healthy volunteers and assessed physiological responses to a single inulin challenge; it did not establish symptom benefit or tolerability in people with IBS.

Source

Published in Aliment Pharmacol Ther. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Gastroenterology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.